Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K/A
2022 FY
Annual report (amended)
16 Mar 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
27 Mar 24
8-K
Other Events
2 Feb 24
8-K
Other Events
25 Jan 24
8-K
Other Events
9 Jan 24
8-K
Other Events
29 Nov 23
8-K
Reports Preliminary Financial Results for Third Quarter 2023 and Provides a Corporate Update
2 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
27 Oct 23
8-K
Entry into a Material Definitive Agreement
8 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
21 Aug 23
8-K
Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
14 Aug 23
Registration and prospectus
424B3
Prospectus supplement
30 Oct 23
S-3/A
Shelf registration (amended)
25 Oct 23
S-3
Shelf registration
5 Oct 23
D
$24.50 mm in equity / options, sold $24.50 mm, 21 investors
22 Sep 23
424B3
Prospectus supplement
5 Dec 22
S-1
IPO registration
23 Nov 22
424B5
Prospectus supplement for primary offering
24 Oct 22
424B5
Prospectus supplement for primary offering
20 Oct 22
S-8
Registration of securities for employees
5 Aug 22
25-NSE
Exchange delisting
16 Apr 21
Proxies
DEF 14A
Definitive proxy
2 Oct 23
PRE 14A
Preliminary proxy
22 Sep 23
DEFA14A
Additional proxy soliciting materials
20 Jun 23
DEFA14A
Additional proxy soliciting materials
14 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFR14A
Revised proxy
7 Jun 22
DEFA14A
Additional proxy soliciting materials
6 Jun 22
DEF 14A
Definitive proxy
29 Apr 22
PRE 14A
Preliminary proxy
19 Apr 22
Other
EFFECT
Notice of effectiveness
31 Oct 23
CORRESP
Correspondence with SEC
26 Oct 23
UPLOAD
Letter from SEC
12 Oct 23
EFFECT
Notice of effectiveness
5 Dec 22
CORRESP
Correspondence with SEC
30 Nov 22
UPLOAD
Letter from SEC
29 Nov 22
EFFECT
Notice of effectiveness
2 Feb 21
CORRESP
Correspondence with SEC
28 Jan 21
UPLOAD
Letter from SEC
28 Jan 21
EFFECT
Notice of effectiveness
21 Aug 20
Ownership
SC 13G/A
Rosalind Advisors, Inc.
25 Apr 24
SC 13G/A
Rosalind Advisors, Inc.
14 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
Lincoln Park Capital Fund, LLC
14 Feb 24
SC 13G/A
LYTTON LAURENCE W
14 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
SC 13G
ADAR1 Partners, LP
31 Jan 24
4
Darrell Shane Lea
12 Dec 23
4
Chad J Kolean
12 Dec 23
4
Andrei Shustov
12 Dec 23